# US 2013/0156713 A1 · Compositions for enhancing nail health

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156713 A1
- Document ID: US20130156713A1
- Status: Published application
- Kind: A1
- Application number: 13/632,746
- Filed: 2012-10-01
- Published: 2013-06-20
- Earliest claimed: 2011-10-05
- Assignees: Allergan, Inc.
- Inventors: John G. Walt
- Web page: https://patentgrep.com/patent/US20130156713A1

## CPC

- A61K 8/42: Amides
- A61K 8/062: {Oil-in-water emulsions}
- A61K 8/361: {Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof}
- A61K 8/492: {having condensed rings, e.g. indol}
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 31/407: condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A61K 31/5575: having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A61K 38/13: Cyclosporins
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/06: Antipsoriatics
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/04: Antibacterial agents
- A61P 31/10: Antimycotics
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61Q 3/00: Manicure or pedicure preparations
- A61Q 3/02: Nail coatings
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention is directed to compositions and methods for enhancing the health of nails and cuticles in a mammal, including humans. The compositions may be administered topically to the nail bed, nail matrix and cuticle in an amount effective to enhance nail health. The composition is also effective in strengthening and growing nails.

## Claims

### Claim 1

A composition for use in enhancing nail health in a human patient, the composition comprising an immunomodulator wherein the composition is in an oil-in-water emulsion, and is topically applied to the nail of the patient.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the immunomodulator is cyclosporine.

### Claim 3 (depends on 1)

The composition of claim 1, further comprising an anti-inflammatory.

### Claim 4 (depends on 3)

The composition of claim 3, wherein the anti-inflammatory is ketorolac.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the emulsion comprises castor oil and a surfactant.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the emulsion comprises at least one component selected from the group consisting of glycerine, polysorbate 80 and carbomer.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the composition comprises 0.5%-1.5% w/w polysorbate 80, 0.5%-1.5% w/w glycerine, 0.5%-1.5% w/w castor oil, 0.05%-0.1% w/w carbomer 1342 and mannitol.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the composition is applied at least once a day.

### Claim 9 (depends on 1)

The composition of claim 1, which is useful for treating brittle nail syndrome.

### Claim 10 (depends on 1)

The composition of claim 1, which is useful for enhancing nail growth.

### Claim 11 (depends on 1)

The composition of claim 1, which is useful for treating a disorder of the nail selected from the group consisting of nail psoriasis, psoriatic nail dystrophy, onychia, onychiagryposis, onychia trophia, onychocryptosis, onychodystrophy, onychogryposis, onycholysis, onychomadesis, onychauxis, onychomycosis, onychorrhexis, tinea unguium, onychophosis, onychoptosis, paronychia, pseudomonas, pterygium and pterygium inversum unguis, koilonychia, subungual hematoma or other trauma to the nail, folic acid deficiency, leukonychia, nail patella syndrome, melanonychia, protein deficiency, brittle and peeling nails, methyl methacrylate damaged nails, vitamin C deficiency, vitamin deficiency, tinea unguis, thinning nails associated with lichen planus, Raynaud's disease, beeding associated with rheumatoid arthritis, beau's lines, and Mee's lines associated with certain kinds of poisoning.

### Claim 12 (depends on 1)

The composition of claim 1, wherein the oil is selected from the group consisting of: Anise oil; Castor oil; Clove oil; Cassia oil; Cinnamon oil; oils having a specific gravity between 0.90 and 0.95; Almond oil; Corn oil; Arachis oil; Cottonseed oil; Safflower oil; Maize oil; Linseed oil; Rapeseed oil; Soybean oil; Olive oil; Caraway oil; Rosemary oil; Peanut oil; Peppermint oil; Sunflower oil; Eucalyptus oil; Sesame oil; an oil having a specific gravity specific gravity below 0.9; Mineral oil; Coriander oil; Lavender oil; Citronella oil; Juniper oil; Lemon oil; Orange oil; Clary sage oil; Nutmeg oil; and, Tea tree oil or mixtures thereof.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the oil-in-water emulsion further contains a surfactant selected from the group consisting of Polysorbate 80, carboxylated and ethoxylated alcohols, amine oxides, block polymers, fatty acids including carboxylic fatty acids, ethoxylated alkyl phenols, ethoxylated fatty esters, glycerol esters, lanolin-based derivatives, lignin derivatives, methyl esters, mono- and tri-glycerides, polyethylene glycols, polymeric surfactants, propoxylated and ethoxylated fatty acids, alcohols, or alkyl phenols, protein based surfactants, sucrose and glucose esters and derivatives or mixtures thereof.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the oil is present in a concentration selected from the group consisting of 1.25% w/v, 0.01%-w/v-10.0% w/v, 0.1% w/v-5.0% w/v, 0.1% w/v-4.0% w/v, 0.1% w/v-3.0% w/v, 0.1% w/v-2.0% w/v, 0.1% w/v-1.0% w/v, 0.1% w/v-0.9% w/v, 0.1% w/v-0.8% w/v, 0.1% w/v-0.8% w/v, 0.1% w/v-0.7% w/v, 0.1% w/v-0.6% w/v, 0.1% w/v-0.5% w/v, 0.1% w/v-0.4% w/v, 0.1% w/v-0.3% w/v, 0.1% w/v-0.2% w/v, 0.09%-0.1% w/v, 0.08%-0.1% w/v, 0.07%-0.1% w/v, 0.06%-0.1% w/v, 0.05%-0.1% w/v, 0.04%-0.1% w/v, 0.03%-0.1% w/v, 0.02%-0.1% w/v, 0.01%-0.1% w/v, 0.01-0.09%, 0.01-0.08% 0.01-0.07% w/v, 0.01-0.06% w/v, 0.01-0.05% w/v, 0.01-0.04% w/v, 0.01-0.03% w/v, 0.01-0.02% w/v, 0.01-0.0125% w/v and 0.05% w/v-5.0% w/v.

### Claim 15 (depends on 1)

The composition of claim 1, wherein the surfactant is present in a concentration selected from the group consisting of 1.0% w/v, 0.01%-w/v-10.0% w/v, 0.1% w/v-5.0% w/v, 0.1% w/v-4.0% w/v, 0.1% w/v-3.0% w/v, 0.1% w/v-2.0% w/v, 0.1% w/v-1.0% w/v, 0.1% w/v-0.9% w/v, 0.1% w/v-0.8% w/v, 0.1% w/v-0.7% w/v, 0.1% w/v-0.6% w/v, 0.1% w/v-0.5% w/v, 0.1% w/v-0.4% w/v, 0.1% w/v-0.3% w/v, 0.1% w/v-0.2% w/v, 0.09%-0.1% w/v, 0.08%-0.1% w/v, 0.07%-0.1% w/v, 0.06%-0.1% w/v, 0.05%-0.1% w/v, 0.04%-0.1% w/v, 0.03%-0.1% w/v, 0.02%-0.1% w/v, 0.01%-0.1% w/v, 0.01-0.09%, 0.01-0.08% 0.01-0.07% w/v, 0.01-0.06% w/v, 0.01-0.05% w/v, 0.01-0.04% w/v, 0.01-0.03% w/v, 0.01-0.02% w/v and 0.01-0.0125% w/v.
